Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban
Authors:
Open Access
- 5 October 2006
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 14 (3) , 211-218
Abstract
Impaired function of the phospholamban (PLB)-regulated sarcoplasmic reticulum Ca2+ pump (SERCA2a) contributes to cardiac dysfunction in heart failure (HF). PLB downregulation may increase SERCA2a activity and improve cardiac function. Small interfering (si)RNAs mediate efficient gene silencing by RNA interference (RNAi). However, their use for in vivo gene therapy is limited by siRNA instability in plasma and tissues, and by low siRNA transfer rates into target cells. To address these problems, we developed an adenoviral vector (AdV) transcribing short hairpin (sh)RNAs against rat PLB and evaluated its potential to silence the PLB gene and to modulate SERCA2a-mediated Ca2+ sequestration in primary neonatal rat cardiomyocytes (PNCMs). Over a period of 13 days, vector transduction resulted in stable >99.9% ablation of PLB-mRNA at a multiplicity of infection of 100. PLB protein gradually decreased until day 7 (7±2% left), whereas SERCA, Na+/Ca2+ exchanger (NCX1), calsequestrin and troponin I protein remained unchanged. PLB silencing was associated with a marked increase in ATP-dependent oxalate-supported Ca2+ uptake at 0.34 μM of free Ca2+, and rapid loss of responsiveness to protein kinase A-dependent stimulation of Ca2+ uptake was maintained until day 7. In summary, these results indicate that AdV-derived PLB-shRNA mediates highly efficient, specific and stable PLB gene silencing and modulation of active Ca2+ sequestration in PNCMs. The availability of the new vector now enables employment of RNAi for the treatment of HF in vivo.Keywords
This publication has 35 references indexed in Scilit:
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Molecular Therapy, 2006
- Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectorsCardiovascular Research, 2006
- Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failureCardiovascular Research, 2005
- Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a β-actin hybrid promoterMolecular Therapy, 2005
- Construction of phospholamban antisense RNA recombinant adeno-associated virus vector and its effects in rat cardiomyocytes1Acta Pharmacologica Sinica, 2005
- Phospholamban ablation by RNA interference increases Ca2+uptake into rat cardiac myocyte sarcoplasmic reticulumJournal of Molecular and Cellular Cardiology, 2004
- A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylationThe FASEB Journal, 2004
- Transgenic overexpression of the sarcoplasmic reticulum Ca 2+ ATPase improves reticular Ca 2+ handling in normal and diabetic rat heartsThe FASEB Journal, 2002
- Expression of Slow Skeletal Troponin I in Hearts of Phospholamban Knockout Mice Alters the Relaxant Effect of β-Adrenergic StimulationCirculation Research, 2002
- The max of the Ca2+-ATPase of Cardiac Sarcoplasmic Reticulum (SERCA2a) Is Not Altered by Ca2+/Calmodulin-dependent Phosphorylation or by Interaction with PhospholambanJournal of Biological Chemistry, 1996